Quarterly report pursuant to Section 13 or 15(d)

Other current liabilities

v3.22.2.2
Other current liabilities
9 Months Ended
Sep. 30, 2022
Other current liabilities  
Other Current Liabilities

5.  Other current liabilities

 

Other current liabilities were comprised of the following items:

 

 

 

September 30,

 

 

December 31,

 

(in thousands)

 

2022

 

 

2021

 

Excise and cannabis tax

 

$ 3,201

 

 

$ 2,830

 

Third party brand distribution accrual

 

 

-

 

 

 

78

 

Insurance and professional fee accrual

 

 

118

 

 

 

651

 

Interest and tax accrual

 

 

590

 

 

 

57

 

Other

 

 

655

 

 

 

90

 

Total other current liabilities

 

$ 4,564

 

 

$ 3,706

 

 

On July 26, 2022, subsidiaries of the Company entered into an agreement with an institutional investor pursuant to which the investor purchased a participation ("Transferred Interests") in all rights to payment from the United States Internal Revenue Service in respect of the Company’s employee retention credits for the first and second quarters of 2021 (the “ERC Claim”). The purchase price paid for the derivative payment rights was $2.45 million, which was paid in immediately available funds. For the three and nine months ended September 30, 2022, the Company recorded net other income of $2,014 and an accrued other liability of $431 to be paid to facilitate the sale of the ERC Claim. Included in interest expense is $863 of financing related charges.